Wednesday, August 03, 2016

          UC Hastings Prof. Rory Little Leads Supreme Court Panel at ABA Annual Meeting

          “Review of the Supreme Court’s Term, Criminal Cases” on Friday, August 5, at 2 pm
          Sample alt tag.
          Professor Rory Little

          This Friday, August 5, at 2 pm, UC Hastings Law Professor Rory Little will moderate his annual “Review of the Supreme Court’s Term, Criminal Cases” panel at the American Bar Association’s Annual Meeting in San Francisco. This will mark the 25th year Professor Little has run this Showcase Panel for the ABA.

          Participating on the panel will be:

          • California Supreme Court Justice Leondra Kruger. Justice Kruger is the youngest member of that Court, and one of the youngest California Supreme Court Justices in history. She was appointed to the Court in January 2015 by Governor Jerry Brown, after a distinguished career in the United States Department of Justice, serving as Deputy Solicitor General among other positions. She is a graduate of Yale Law School, served as a law clerk to U.S. Supreme Court Justice John Paul Stevens, and has argued 12 cases in the United States Supreme Court.
          • The Honorable Brian Stretch, the United States Attorney for the Northern District of California. Mr. Stretch has been a career prosecutor for over twenty years, in both federal and state courts in California. He oversees the operations of one of the largest federal prosecution units in the country, supervising well over 100 federal attorneys and a staff of over 250, ranging from San Jose to the Oregon border and covering almost a quarter of California’s 38 million people.
          • Nationally recognized appellate advocate Dennis Riordan, whose lengthy career as an appellate specialist has included representation of, among many others, famed baseball star Barry Bonds; wrongfully accused young men known as the “West Memphis Three;” accused Black Panther Johnny Spain; former San Francisco Bar Association President e. bob wallach; and various publicized white collar and securities law defendants.

          The panel will begin at 2 pm this Friday in the Moscone Center West, Room 3014, 747 Howard Street in San Francisco. For more information please contact Professor Little at littler@uchastings.edu, Cell: 415-225-5190; or UC Hastings Director of External Relations Alex A.G. Shapiro at shapiroa@uchastings.edu, Cell: (415) 813-9214.

          ###

          Go to News Archive

          Share this Story

          Share via Facebook
          Share via TwitterShare via EmailPrint Friendly Version

          Other Recent Stories/ RSS

          Monday, November 20, 2017

          Professor Carol Izumi receives 2018 William Pincus Award for Outstanding Service and Commitment to Clinical Legal Education from the Association of American Law Schools (AALS)

          “Recipients are giants in the field and Carol belongs in their midst,” says Associate Dean Ascanio Piomelli.
          Friday, November 17, 2017

          Exciting New Spring 2018 Courses Focus on the Future

          Grabbing from the headlines and emphasizing innovation, courses like Legal Tech Startups, Advanced Immigration Law, and Stalking and Law will prepare UC Hastings students for next-level legal careers.
          Tuesday, November 14, 2017

          Port pilot John Betz ’96 discusses his non-legal career and the importance of education

          A tragic “Deadliest Catch” moment piqued a lifelong interest in the law and encouraged John to pursue a law degree at UC Hastings.
          Friday, November 03, 2017

          Thinkers & Doers: October 2017

          100 Things Warriors Fans Should Know & Do Before They Die -- Alum appointed Chargé d’Affaires -- The poisonous dynamic over who’s to blame for racism -- Prof. Williams on the Harvey Weinstein Effect -- Two More UC Hastings Grads Receive Judgeships from Gov. Brown -- Jury selection in the Steinle case -- and much more
          Wednesday, November 01, 2017

          Why do drug prices remain so high?

          "Because drug companies block competition," says Professor Feldman in a new study that examines all drugs on the market between 2005 and 2015, identifying and analyzing every instance in which the company added new patents or exclusivities. 
          Go to News Archive